On a preliminary basis, Baxter International (NYSE:BAX) expects Q4 and full-year sales of ~$3.0B and ~$11.4B, respectively.
Operating margin should be above guidance of 15.2 – 15.9% of sales.
2020 guidance: Sales growth: 4 – 5%; operating margin: 17 – 18%. More detailed guidance will be released when it reports Q4 and 2019 results which will be later than usual due to its ongoing internal investigation into certain intra-company transactions aimed at generating non-operating foreign exchange gains or avoiding losses (first disclosed in October 2019).
#JPM20
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.